This inventor holds 4 USPTO granted patents and 1 EPO patent. Top assignees: Adienne Srl, Adienne S.a., Quark Pharmaceuticals, Inc.. Active years: 2011-2015.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Munrupino, IT (2011)
- Trieste, IT (2011 - 2015)
Company Filing History:
Years Active: 2011-2015
Title: Roberto Marzari: Inventor in Complement-Targeted Therapeutics
Introduction
Roberto Marzari is an inventor associated with Trieste, Italy. His patent work includes recombinant antibodies designed to target the C5 component of the activated complement system. He is associated with 4 patents.
Latest Patents
Two of Marzari’s latest patent titles are “Anti-C5 Alpha Antibodies” and “Methods of Treating a Disease with Anti-C5 Alpha Antibodies.” Both describe human-origin recombinant antibodies that bind the C5 component and inhibit the conversion of its alpha chain into C5a and C5b.
The inventions also cover nucleotide sequences encoding these antibodies and their potential therapeutic use. The described applications include treating diseases involving tissue damage caused by uncontrolled activation of the complement system.
Career Highlights
Marzari’s professional affiliations include Adienne Srl and Quark Pharmaceuticals, Inc. His patent work reflects a focus on antibody-based approaches to complement-related disease.
Collaborations
His listed coworkers include Francesco Tedesco and Daniele Sblattero. Their shared professional context includes research and development related to biotechnology and therapeutic inventions.
Conclusion
Roberto Marzari’s patent portfolio highlights antibody and nucleotide-based approaches aimed at controlling complement activation and addressing related tissue damage.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile